Case report: fatal leptospira spp./Zika virus coinfection-Puerto Rico, 2016

American Journal of Tropical Medicine and Hygiene

Volumn 97, Issue 4, 2017, Pages 1085-1087

  Neaterour, Paige ^a   Rivera, Aidsa ^a   Galloway, Renee L ^b   Negrón, Myriam Garcia ^c   Rivera Garcia, Brenda ^c   Sharp, Tyler M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c Health Department   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; INFUSION FLUID; NUCLEIC ACID; PARACETAMOL; RANITIDINE;

ADULT; ARTICLE; AUTOPSY; CHIKUNGUNYA; CLINICAL ARTICLE; DENGUE; DIAGNOSTIC TEST; DIARRHEA; DIFFERENTIAL DIAGNOSIS; FATALITY; FEVER; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; HYPOTENSION; KIDNEY FAILURE; LEPTOSPIROSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; MOLECULAR DIAGNOSIS; MYALGIA; NAUSEA; NONHUMAN; PUERTO RICO; RECTUM HEMORRHAGE; RISK FACTOR; SEROLOGY; THROMBOCYTOPENIA; VOMITING; ZIKA FEVER; CASE REPORT; COINFECTION; MORTALITY; ZIKA VIRUS INFECTION;

COINFECTION; FATAL OUTCOME; HUMANS; LEPTOSPIROSIS; MALE; MIDDLE AGED; PUERTO RICO; ZIKA VIRUS INFECTION;

EID: 85031706371     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.17-0250     Document Type: Article

References (20)

1. KatzAR, AnsdellVE, Effler PV, MiddletonCR, Sasaki DM, 2001. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. Clin Infect Dis 33: 1834-1841.
2. Amilasan AS, Ujiie M, Suzuki M, Salva E, Belo MC, Koizumi N, Yoshimatsu K, Schmidt WP, Marte S, Dimaano EM, Villarama JB, Ariyoshi K, 2012. Outbreak of leptospirosis after flood, the Philippines, 2009. Emerg Infect Dis 18: 91-94.
3. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM; Peru-United States Leptospirosis Consortium, 2003. Leptospirosis: A zoonotic disease of global importance. Lancet Infect Dis 3: 757-771.
4. Daher EF, Lima RS, Silva Júnior GB, Silva EC, Karbage NN, Kataoka RS, Carvalho Júnior PC, Magalhães MM, Mota RM, Libório AB, 2010. Clinical presentation of leptospirosis: A retrospective study of 201 patients in a metropolitan city of Brazil. Braz J Infect Dis 14: 3-10.
5. Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, Stein C, Abela-Ridder B, Ko AI, 2015. Global morbidity and mortality of leptospirosis: A systematic review. PLoS Negl Trop Dis 9: e0003898.
6. Petersen LR, Jamieson DJ, Powers AM, Honein MA, 2016. Zika virus. N Engl J Med 374: 1552-1563.
7. Sharp TM, Muñoz-Jordán J, Perez-Padilla J, Bello-Pagán MI, RiveraA, PastulaDM, Salinas JL, MartinezMendez JH, Méndez M, Powers AM, Waterman S, Rivera-Garca B, 2016. Zika virus infection associated with severe thrombocytopenia. Clin Infect Dis 63: 1198-1201.
8. Dirlikov E, Major CG, Mayshack M, Medina N, Matos D, Ryff KR, Torres-Aponte J, Alkis R, Munoz-Jordan J, Colon-Sanchez C, Salinas JL, Pastula DM, Garcia M, Segarra MO, Malave G, Thomas DL, Rodrguez-Vega GM, Luciano CA, Sejvar J, Sharp TM, Rivera-Garcia B, 2016. Guillain-Barrésyndrome during ongoing Zika virus transmission-Puerto Rico, January 1-July 31, 2016. MMWR Morb Mortal Wkly Rep 65: 910-914.
9. Lozier M, Adams L, Febo MF, Torres-Aponte J, Bello-Pagan M, Ryff KR, Munoz-Jordan J, Garcia M, Rivera A, Read JS, Waterman SH, Sharp TM, Rivera-Garcia B, 2016. Incidence of Zika virus disease by age and sex-Puerto Rico, November 1, 2015-October 20, 2016. MMWR Morb Mortal Wkly Rep 65: 1219-1223.
10. Sharp TM, Rivera Garca B, Pérez-Padilla J, Galloway RL, Guerra M, Ryff KR, Haberling D, Ramakrishnan S, Shadomy S, Blau D, Tomashek KM, Bower WA, 2016. Early indicators of fatal leptospirosis during the 2010 epidemic in Puerto Rico. PLoS Negl Trop Dis 10: e0004482.
11. SergioADM, FigueroaEG, SaadiaVM, ElizabethS, Beatriz R, Vctor MAA, Espinosa JN, 2012. Leptospirosis prevalence in patients with initial diagnosis of dengue. J Trop Med 2012: 519701.
12. Ellis T, Imrie A, Katz KR, Effler PV, 2008. Underrecognition of leptospirosis during a dengue fever outbreak in Hawaii, 2001-2002. Vector Borne Zoonotic Dis 8: 541-547.
13. Nhan TX, Bonnieux E, Rovery C, De Pina JJ, Musso D, 2016. Fatal leptospirosis and chikungunya co-infection: do not forget leptospirosis during chikungunya outbreaks. IDCases 22: 12-14.
14. Biron A, Cazorla C, Amar J, Pfannstiel A, Dupont-Rouzeyrol M, Goarant C, 2016. Zika virus infection as an unexpected finding in a Leptospirosis patient. JMM Case Rep 3: e005033.
15. Centers for Disease Control and Prevention, 2016. Trioplex Real-time RT-PCR Assay. Available at: http://www. fda. gov/ downloads/MedicalDevices/Safety/EmergencySituations/ UCM491592. pdf. Accessed February 8, 2017.
16. Stoddard RA, Gee JE, Wilkins PP, McCaustland K, Hoffmaster AR, 2009. Detection of pathogenic Leptospira spp. Through TaqMan polymerase chain reaction targeting the LipL32 gene. Diagn Microbiol Infect Dis 64: 247-255.
17. Rajapakse S, Rodrigo C, Handunnetti SM, Deepika S, 2015. Current immunological and molecular tools for leptospirosis: diagnostics, vaccine design, and biomarkers for predicting severity. Ann Clin Microbiol Antimicrob 14: 1-8.
18. Agampodi SB, Dahanayaka NJ, Nockler K, Anne MS, Vinetz JM, 2016. Redefining gold standard testing for diagnosing leptospirosis: further evidence from a well-characterized, floodrelated outbreak in Sri Lanka. AmJ Trop Med Hyg 95: 531-536.
19. Nabity SA, Ribeiro GS, Aquino CL, Takahashi D, Damião AO, Gonçalves AH, Miranda-Filho DB, Greenwald R, Esfandiari J, LyashchenkoKP, ReisMG, MedeirosMA, KoAI, 2012. Accuracy of a dual path platform (DPP) assay for the rapid point-of-care diagnosis of human leptospirosis. PLoS Negl Trop Dis 6: e1878.
20. CohenAL, McMorrowM, Walaza S, Cohen C, Tempia S, Alexander-ScottM, Widdowson MA, 2015. Potential impact of co-infections and co-morbidities prevalent in Africa on influenza severity and frequency: A systematic review. PLoS One 10: e0128580.